s6y Cascadian Therapeutics, Inc. EFFECT

Cascadian Therapeutics, Inc. EFFECT, filed Mar 21, 2018: primary_doc.xml

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: March 21, 2018
Accession Number: 0001193125-18-076377
Submission Type: POS AM
CIK: 0001412067
Company Name: Cascadian Therapeutics, Inc.
File Number: 333-222362